PW Medtech (01358) has announced that it repurchased 473,000 shares on September 2, 2026, at a total cost of HK$431,400.
The buyback reflects the company's ongoing capital management strategy, as it continues to utilize its resources to enhance shareholder value through share repurchases in the open market.